These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 21339220)

  • 21. Autoantibodies to citrullinated proteins: ACPA.
    Vincent C; Nogueira L; Clavel C; Sebbag M; Serre G
    Autoimmunity; 2005 Feb; 38(1):17-24. PubMed ID: 15804701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
    van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR
    Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of autoantibodies against citrullinated antigens/peptides by human B cells.
    Bellatin MF; Han M; Fallena M; Fan L; Xia D; Olsen N; Branch V; Karp D; Stastny P
    J Immunol; 2012 Apr; 188(7):3542-50. PubMed ID: 22345652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis.
    Rombouts Y; Ewing E; van de Stadt LA; Selman MH; Trouw LA; Deelder AM; Huizinga TW; Wuhrer M; van Schaardenburg D; Toes RE; Scherer HU
    Ann Rheum Dis; 2015 Jan; 74(1):234-41. PubMed ID: 24106048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
    Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
    Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies.
    Anquetil F; Clavel C; Offer G; Serre G; Sebbag M
    J Immunol; 2015 Apr; 194(8):3664-74. PubMed ID: 25769920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Reynisdottir G; Karimi R; Joshua V; Olsen H; Hensvold AH; Harju A; Engström M; Grunewald J; Nyren S; Eklund A; Klareskog L; Sköld CM; Catrina AI
    Arthritis Rheumatol; 2014 Jan; 66(1):31-9. PubMed ID: 24449573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis.
    van de Stadt LA; de Koning MH; van de Stadt RJ; Wolbink G; Dijkmans BA; Hamann D; van Schaardenburg D
    Arthritis Rheum; 2011 Nov; 63(11):3226-33. PubMed ID: 21792832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating plasmablasts/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritis.
    Kerkman PF; Rombouts Y; van der Voort EI; Trouw LA; Huizinga TW; Toes RE; Scherer HU
    Ann Rheum Dis; 2013 Jul; 72(7):1259-63. PubMed ID: 23625975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
    Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
    Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis.
    Vander Cruyssen B; Nogueira L; Van Praet J; Deforce D; Elewaut D; Serre G; De Keyser F
    Ann Rheum Dis; 2008 Apr; 67(4):542-6. PubMed ID: 17644546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons.
    Alivernini S; Galeazzi M; Peleg H; Tolusso B; Gremese E; Ferraccioli G; Naparstek Y
    Autoimmun Rev; 2017 Nov; 16(11):1096-1102. PubMed ID: 28899798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients.
    Feitsma AL; Toes RE; Begovich AB; Chokkalingam AP; de Vries RR; Huizinga TW; van der Helm-van Mil AH
    Rheumatology (Oxford); 2007 Jul; 46(7):1092-5. PubMed ID: 17341507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis.
    Suwannalai P; van de Stadt LA; Radner H; Steiner G; El-Gabalawy HS; Zijde CM; van Tol MJ; van Schaardenburg D; Huizinga TW; Toes RE; Trouw LA
    Arthritis Rheum; 2012 May; 64(5):1323-8. PubMed ID: 22130974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is the ability of anti-cyclic citrullinated peptide antibodies determination in synovial fluid in discriminating rheumatoid arthritis from non-rheumatoid arthritis patients? A Tunisian cross-sectional study.
    Mrabet D; Laadhar L; Sahli H; Zouari B; Haouet S; Lahmar H; Makni S; Sellami S
    Clin Rheumatol; 2012 Feb; 31(2):375-9. PubMed ID: 21952975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen.
    Clavel C; Nogueira L; Laurent L; Iobagiu C; Vincent C; Sebbag M; Serre G
    Arthritis Rheum; 2008 Mar; 58(3):678-88. PubMed ID: 18311806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities.
    Ioan-Facsinay A; el-Bannoudi H; Scherer HU; van der Woude D; Ménard HA; Lora M; Trouw LA; Huizinga TW; Toes RE
    Ann Rheum Dis; 2011 Jan; 70(1):188-93. PubMed ID: 20736390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens.
    Suwannalai P; Scherer HU; van der Woude D; Ioan-Facsinay A; Jol-van der Zijde CM; van Tol MJ; Drijfhout JW; Huizinga TW; Toes RE; Trouw LA
    Ann Rheum Dis; 2011 Feb; 70(2):373-9. PubMed ID: 21068094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
    Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
    Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.